Samples
Manage and track biological samples across studies
Total Samples
930
Cell Types
19
Conditions
19
Studies
42
Filters
Sample Data
Showing 50 of 930 samples| NAME | SUBJECT ID | CELL TYPE | CONDITION | ASSAYS | COLLECTION DATE | ACTIONS | |
|---|---|---|---|---|---|---|---|
|
Boss9_3.Veh.NA.C
|
Boss9_3
|
PBMC | Control |
10
scRNA-seq,
CITE-seq
...
|
2024-04-11 | ||
|
Boss9_4.COVID.NA.C
|
Boss9_4
|
PBMC | Control |
7
scATAC-seq,
ASAP-seq
...
|
2024-04-18 | ||
|
Boss9_5.Veh.NA.C
|
Boss9_5
|
PBMC | Control |
10
scRNA-seq,
CITE-seq
...
|
2024-04-18 | ||
|
Boss9_6.COVID.NA.C
|
Boss9_6
|
PBMC | Control |
7
scRNA-seq,
CITE-seq
...
|
2024-04-18 | ||
|
Boss9_7.COVID.NA.C
|
Boss9_7
|
PBMC | Control |
7
scATAC-seq,
ASAP-seq
...
|
2024-04-18 | ||
|
R042.COVID.PostV1.RTX
|
R042
|
PBMC | RTX |
7
scRNA-seq,
CITE-seq
...
|
2024-04-18 | ||
|
R025.Veh.PreVaccine.RTX
|
R025
|
PBMC | RTX |
10
scRNA-seq,
CITE-seq
...
|
2024-04-18 | ||
|
F451.Veh.PreVaccine.MMF
|
F451
|
PBMC | MMF |
5
scRNA-seq,
CITE-seq
...
|
2024-04-23 | ||
|
R086.Veh.PreVaccine.MMF
|
R086
|
PBMC | MMF |
5
scRNA-seq,
CITE-seq
...
|
2024-04-23 | ||
|
Boss9_8.Veh.NA.C
|
Boss9_8
|
PBMC | Control |
5
scRNA-seq,
CITE-seq
...
|
2024-04-23 | ||
|
Boss9_9.COVID.NA.C
|
Boss9_9
|
PBMC | Control |
2
scATAC-seq,
ASAP-seq
|
2024-04-23 | ||
|
R046.Veh.PreVaccine.MMF
|
R046
|
PBMC | MMF |
2
scATAC-seq,
ASAP-seq
|
2024-04-25 | ||
|
R064.Veh.PreVaccine.MMF
|
R064
|
PBMC | MMF |
2
scATAC-seq,
ASAP-seq
|
2024-04-25 | ||
|
Boss9_10.Veh.NA.C
|
Boss9_10
|
PBMC | Control |
2
scATAC-seq,
ASAP-seq
|
2024-04-25 | ||
|
Boss9_11.COVID.NA.C
|
Boss9_11
|
PBMC | Control |
5
scRNA-seq,
CITE-seq
...
|
2024-04-25 | ||
|
Boss9_12.COVID.NA.C
|
Boss9_12
|
PBMC | Control |
5
scRNA-seq,
CITE-seq
...
|
2024-04-25 | ||
|
ACE.MS.058.d.CMV.PostV1.RTX
|
ACE.MS.058
|
PBMC | RTX |
2
scATAC-seq,
ASAP-seq
|
2024-02-28 | ||
|
ACE.MS.067.d.CMV.PostV1.RTX
|
ACE.MS.067
|
PBMC | RTX |
2
scATAC-seq,
ASAP-seq
|
2024-02-28 | ||
|
R042.CMV.PostV1.RTX
|
R042
|
PBMC | RTX |
2
scATAC-seq,
ASAP-seq
|
2024-02-28 | ||
|
ACE.MS.058.d.COVID.PostV1.RTX
|
ACE.MS.058
|
PBMC | RTX |
2
scATAC-seq,
ASAP-seq
|
2024-02-28 | ||
|
ACE.MS.067.d.COVID.PostV1.RTX
|
ACE.MS.067
|
PBMC | RTX |
2
scATAC-seq,
ASAP-seq
|
2024-02-28 | ||
|
Ecto-2
|
— | CD45+ Leukocytes | — |
2
scRNA-seq,
scVDJ-seq
|
— | ||
|
Uterus-2
|
— | CD45+ Leukocytes | — |
2
scRNA-seq,
scVDJ-seq
|
— | ||
|
1A.1.Spleen.IN.TEM
|
1A
|
CD8+ TEM | Intranasally (IN) infected |
1
Bulk RNA-seq
|
— | ||
|
1B.1.Spleen.IP.TEM
|
1B
|
CD8+ TEM | Intraperitoneally (IP) infected |
1
Bulk RNA-seq
|
— | ||
|
1C.1.NC.IN.TRM
|
— | CD8+ TRM | Intranasally (IN) infected |
1
Bulk RNA-seq
|
— | ||
|
1E.1.NC.IP.TRM
|
— | CD8+ TRM | Intraperitoneally (IP) infected |
1
Bulk RNA-seq
|
— | ||
|
2A.1.Spleen.IN.TEM
|
— | CD8+ TEM | Intranasally (IN) infected |
1
Bulk RNA-seq
|
— | ||
|
2B.1.Spleen.IP.TEM
|
— | CD8+ TEM | Intraperitoneally (IP) infected |
1
Bulk RNA-seq
|
— | ||
|
2C.1.NC.IN.TRM
|
— | CD8+ TRM | Intranasally (IN) infected |
1
Bulk RNA-seq
|
— | ||
|
2E.1.NC.IP.TRM
|
— | CD8+ TRM | Intraperitoneally (IP) infected |
1
Bulk RNA-seq
|
— | ||
|
3A.1.Spleen.IN.TEM
|
— | CD8+ TEM | Intranasally (IN) infected |
1
Bulk RNA-seq
|
— | ||
|
3B.1.Spleen.IP.TEM
|
— | CD8+ TEM | Intraperitoneally (IP) infected |
1
Bulk RNA-seq
|
— | ||
|
3C.1.NC.IN.TRM
|
— | CD8+ TRM | Intranasally (IN) infected |
1
Bulk RNA-seq
|
— | ||
|
3E.1.NC.IP.TRM
|
— | CD8+ TRM | Intraperitoneally (IP) infected |
1
Bulk RNA-seq
|
— | ||
|
4A.1.Spleen.IN.TEM
|
— | CD8+ TEM | Intranasally (IN) infected |
1
Bulk RNA-seq
|
— | ||
|
4B.1.Spleen.IP.TEM
|
— | CD8+ TEM | Intraperitoneally (IP) infected |
1
Bulk RNA-seq
|
— | ||
|
4C.1.NC.IN.TRM
|
— | CD8+ TRM | Intranasally (IN) infected |
1
Bulk RNA-seq
|
— | ||
|
dummy_sample
|
— | — | — | 0 | — | ||
|
KF001-HTC1
|
3005
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF001-HTC2
|
3536
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF001-HTC3
|
2644
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF001-HTC4
|
2708
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF001-HTC5
|
2583
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF001-HTC6
|
2644
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF001-HTC7
|
2708
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF001-HTC8
|
3536
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF002-HTC1
|
3005
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF002-HTC2
|
3536
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF002-HTC3
|
2644
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 |